These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20847451)
1. FK506 reduces amyloid plaque burden and induces MMP-9 in AβPP/PS1 double transgenic mice. Hong HS; Hwang JY; Son SM; Kim YH; Moon M; Inhee MJ J Alzheimers Dis; 2010; 22(1):97-105. PubMed ID: 20847451 [TBL] [Abstract][Full Text] [Related]
2. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain. Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease and amyloid: culprit or coincidence? Skaper SD Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404 [TBL] [Abstract][Full Text] [Related]
5. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075 [TBL] [Abstract][Full Text] [Related]
6. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model. Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314 [TBL] [Abstract][Full Text] [Related]
7. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
8. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model. Faivre E; Hölscher C J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101 [TBL] [Abstract][Full Text] [Related]
9. Elevation of zinc transporter ZnT3 protein in the cerebellar cortex of the AbetaPP/PS1 transgenic mouse. Zheng W; Wang T; Yu D; Feng WY; Nie YX; Stoltenberg M; Danscher G; Wang ZY J Alzheimers Dis; 2010; 20(1):323-31. PubMed ID: 20164588 [TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Toledo EM; Inestrosa NC Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015 [TBL] [Abstract][Full Text] [Related]
11. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014 [TBL] [Abstract][Full Text] [Related]
12. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease. Duffy AM; Hölscher C Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794 [TBL] [Abstract][Full Text] [Related]
13. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease. Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312 [TBL] [Abstract][Full Text] [Related]
15. Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice. van Groen T; Kadish I; Funke SA; Bartnik D; Willbold D J Alzheimers Dis; 2013; 34(3):609-20. PubMed ID: 23271316 [TBL] [Abstract][Full Text] [Related]
16. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease. He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026 [TBL] [Abstract][Full Text] [Related]
18. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice. Fragkouli A; Tsilibary EC; Tzinia AK Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761 [TBL] [Abstract][Full Text] [Related]
20. Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease. Pérez-González R; Antequera D; Vargas T; Spuch C; Bolós M; Carro E J Alzheimers Dis; 2011; 24 Suppl 2():17-25. PubMed ID: 21335656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]